Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Kush Parmar


  • Large Shareholder at Cabaletta Bio Inc. (CABA), 2019-10-31
  • Large Shareholder at Aprea Therapeutics Inc. (APRE), 2019-10-09
  • Director at Arvinas Inc. (ARVN), 2019-09-26
  • Large Shareholder, Director at Homology Medicines Inc. (FIXX), 2019-06-10
  • Director at Scpharmaceuticals Inc. (SCPH), 2018-06-21
  • Director at Audentes Therapeutics Inc. (BOLD), 2018-06-08
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
FIXX $21.47 24,600 Large Shareholder, Director 221,435 2019-05-16 Filing
FIXX $21.47 590,400 Large Shareholder, Director 5,314,484 2019-05-16 Filing
FIXX $26.01 623 Large Shareholder, Director 246,035 2018-12-10 Filing
FIXX $26.01 14,952 Large Shareholder, Director 5,904,884 2018-12-10 Filing
FIXX $20.04 1,187 Large Shareholder, Director 246,658 2018-11-23 Filing